TD&E Research

TD&E Research Helping Advance Medicine through Clinical Trials in the Austin Area! Located in Round Rock, Central

💙 Do you have type 1 diabetes?You may qualify for a new clinical study exploring how a once-weekly insulin, insulin icod...
11/21/2025

💙 Do you have type 1 diabetes?

You may qualify for a new clinical study exploring how a once-weekly insulin, insulin icodec, helps manage blood sugar compared to daily insulin.

Participating in this study could help you:
✔ Take a more active role in managing your diabetes
✔ Receive regular expert medical care
✔ Contribute to medical research that may benefit others

The ONWARDS 11 study is currently recruiting volunteers in Central Texas.

To learn more, contact TDE Research at 512-334-3505 (Option 4).

💙 Walking for a Cure! 💙Earlier this month, our team had the pleasure of hosting a table at the Breakthrough T1D Walk at ...
11/20/2025

💙 Walking for a Cure! 💙

Earlier this month, our team had the pleasure of hosting a table at the Breakthrough T1D Walk at Dell Diamond! As always, it was inspiring to see so many families, patients, and community partners come together in support of type 1 diabetes research and awareness.

We’re proud to be part of a community dedicated to breakthroughs in care and a brighter future for everyone living with diabetes.

Thank you to everyone who stopped by to say hello — we loved meeting you!

Learn more about our type 1 diabetes study now enrolling at Texas Diabetes Research. Contact us today at 512-334-3505 or...
11/06/2025

Learn more about our type 1 diabetes study now enrolling at Texas Diabetes Research. Contact us today at 512-334-3505 or visit texasdiabetes.com to learn more.

Contact our research team to find out if you are a candidate! 512-334-3505
11/04/2025

Contact our research team to find out if you are a candidate! 512-334-3505

We are enrolling people who have been diagnosed with Stage 3 Type 1 diabetes (T1D) within the last 6 months in a clinica...
11/03/2025

We are enrolling people who have been diagnosed with Stage 3 Type 1 diabetes (T1D) within the last 6 months in a clinical trial for our investigational, first-in-class, antigen-specific therapy, CNP-103.
CNP-103 is designed to preserve insulin production by targeting the autoimmune attack on beta cells, which may improve blood sugar control and long-term outcomes.

Interested in participating or sharing with someone who might qualify? Contact us at 512-334-3505 to learn more.

Now enrolling! Contact us at 512-334-3505 to learn more or visit texasdiabetes.com to learn more.
10/30/2025

Now enrolling! Contact us at 512-334-3505 to learn more or visit texasdiabetes.com to learn more.

If you are living with type 2 diabetes and struggling to control your blood glucose, contact us at 512-334-3505 to learn...
10/29/2025

If you are living with type 2 diabetes and struggling to control your blood glucose, contact us at 512-334-3505 to learn about a new research study for an oral study medication.

Adults ages 22-70 with Type 2 diabetes who are taking 1-4 non-insulin diabetes medications and not adequately controlled...
10/28/2025

Adults ages 22-70 with Type 2 diabetes who are taking 1-4 non-insulin diabetes medications and not adequately controlled on their current therapy my be eligible. Contact us at 512-334-3505 to learn more.

10/27/2025

Seeking adults for a T1DM study researching an investigational drug for hypoglycemia. Contact us at (512) 458-8400 to learn more.

We are enrolling people who have been diagnosed with Stage 3 Type 1 diabetes (T1D) within the last 6 months in a clinica...
10/24/2025

We are enrolling people who have been diagnosed with Stage 3 Type 1 diabetes (T1D) within the last 6 months in a clinical trial for our investigational, first-in-class, antigen-specific therapy, CNP-103.

CNP-103 is designed to preserve insulin production by targeting the autoimmune attack on beta cells, which may improve blood sugar control and long-term outcomes.

Interested in participating or sharing with someone who might qualify? Contact us at 512-334-3505 to learn more.

We are enrolling people who have been diagnosed with Stage 3 Type 1 diabetes (T1D) within the last 6 months in a clinica...
10/22/2025

We are enrolling people who have been diagnosed with Stage 3 Type 1 diabetes (T1D) within the last 6 months in a clinical trial for our investigational, first-in-class, antigen-specific therapy, CNP-103.
CNP-103 is designed to preserve insulin production by targeting the autoimmune attack on beta cells, which may improve blood sugar control and long-term outcomes.

Interested in participating or sharing with someone who might qualify? Contact us at 512-334-3505 to learn more.

Address

6500 N Mopac Expressway, Bldg 3, Ste 200
Austin, TX
78731

Opening Hours

Monday 7am - 4:30pm
Tuesday 7am - 4:30pm
Wednesday 7am - 4:30pm
Thursday 7am - 4:30pm
Friday 7am - 4:30pm

Website

Alerts

Be the first to know and let us send you an email when TD&E Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category